Nuvation Bio to report Q3 2026 financial results in November webcast

Nuvation Bio, a global oncology company, announced it will hold a webcast on November 4, 2026, to discuss its third quarter financial results and business updates. The event will be accessible to investors and the public via live call and webcast, with a recording available for 90 days. This update is important as it provides insights into the company's progress in developing cancer therapies, including its pipeline drugs like taletrectinib and safusidenib. Investors can register on Nuvation Bio's website to participate.

Nuvation Bio's stock trades at USD 4.88 on Pluang as of Oct 22, 2026 03:11 WIB. The share price has risen by 2.31% in the past day. The company has a market cap of $1.57 billion on the platform, indicating significant investor interest ahead of its upcoming financial results webcast.